American Society of Clinical Oncology (ASCO), 2025

Authors

Kaissa Ouali¹, Christophe Massard¹, Antoine Hollebecque¹, Yohann Loriot¹, Aurélien Marabelle¹, Capucine Baldini¹, Ivan Panico², Younes Youssfi², Arlindo Ferreira², Alexandre Yazigi², Charles Ferté², Fabrice Barlesi³, Fabrice André^3,4, Maria Alice Franzoi^3,5

‍

Affiliation

1. Gustave Roussy, Drug Development Department (DITEP), Villejuif, France; 2.Resilience Care, Paris, France; 3.Gustave Roussy Institute, Villejuif, France; 4.Gustave Roussy, INSERM U981, Université Paris-Saclay, IHU-National PRecISion Medicine Center in Oncology, Villejuif, France; 5.Cancer Survivorship Program, INSERM Unit 981, Gustave Roussy, Villejuif, France.

‍

Introduction

Cancer in individuals under 40 is rapidly becoming a major public health concern. These patients exhibit unique health behaviors, distinct from those observed in older populations. Concurrently, they often face specific physical, psychosocial, and socioeconomic challenges that can influence clinical outcomes. Yet, these aspects are frequently underestimated in standard care pathways.

Digital health solutions, particularly remote patient monitoring (RPM), offer an opportunity to bridge these gaps by enabling continuous, systematic, standardized assessment and more personalized follow-up.

This study, presented at ASCO 2025, explores the health behaviors of these young adult patients, their impact on perceived symptom burden, and their adherence to remote monitoring.